Literature DB >> 22732594

Critical role for CCAAT/enhancer-binding protein β in immune complex-induced acute lung injury.

Chunguang Yan1, Min Wu, Jay Cao, Huifang Tang, Mei Zhu, Peter F Johnson, Hongwei Gao.   

Abstract

C/EBPs, particularly C/EBPβ and C/EBPδ, are known to participate in the regulation of many genes associated with inflammation. However, very little is known regarding the activation and functions of C/EBPβ and C/EBPδ in acute lung inflammation and injury. In this study, we show that both C/EBPβ and C/EBPδ activation are triggered in lungs and in alveolar macrophages following intrapulmonary deposition of IgG immune complexes. We further show that mice carrying a targeted deletion of the C/EBPβ gene displayed significant attenuation of the permeability index (lung vascular leak of albumin), lung neutrophil accumulation (myeloperoxidase activity), total number of WBCs, and neutrophils in bronchoalveolar lavage fluids compared with wild-type mice. Moreover, the mutant mice expressed considerably less TNF-α, IL-6, and CXC/CC chemokine and soluble ICAM-1 proteins in bronchoalveolar lavage fluids, and corresponding mRNAs in the IgG immune complex-injured lung, compared with wild-type mice. These phenotypes were associated with a significant reduction in morphological lung injury. In contrast, C/EBPδ deficiency had no effect on IgG immune complex-induced lung injury. IgG immune complex-stimulated C/EBPβ-deficient alveolar macrophages released significantly less TNF-α, IL-6, MIP-2, keratinocyte cell-derived chemokine, and MIP-1α compared with wild-type cells. Similar decreases in IgG immune complex-induced inflammatory mediator production were observed following small interfering RNA ablation of C/EBPβ in a murine alveolar macrophage cell line. These findings implicate C/EBPβ as a critical regulator of IgG immune complex-induced inflammatory responses and injury in the lung.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732594      PMCID: PMC3401325          DOI: 10.4049/jimmunol.1200877

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages.

Authors:  Chunguang Yan; Mei Zhu; Jennifer Staiger; Peter F Johnson; Hongwei Gao
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.

Authors:  B Hu; M R Ullenbruch; H Jin; M Gharaee-Kermani; S H Phan
Journal:  J Pathol       Date:  2007-03       Impact factor: 7.996

3.  Lung epithelial CCAAT/enhancer-binding protein-β is necessary for the integrity of inflammatory responses to cigarette smoke.

Authors:  Lukas Didon; Jenny L Barton; Abraham B Roos; Gordon J Gaschler; Carla M T Bauer; Tove Berg; Martin R Stämpfli; Magnus Nord
Journal:  Am J Respir Crit Care Med       Date:  2011-05-11       Impact factor: 21.405

Review 4.  Transcriptional mechanisms of acute lung injury.

Authors:  J Fan; R D Ye; A B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

5.  JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPβ transcription.

Authors:  Kunming Zhang; Wei Guo; Ying Yang; Jiarui Wu
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

6.  An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation.

Authors:  Huifang Tang; Chunguang Yan; Jay Cao; J Vidya Sarma; Eric B Haura; Min Wu; Hongwei Gao
Journal:  FASEB J       Date:  2011-08-22       Impact factor: 5.191

7.  Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats.

Authors:  N M Bless; M Huber-Lang; R F Guo; R L Warner; H Schmal; B J Czermak; T P Shanley; L D Crouch; A B Lentsch; V Sarma; M S Mulligan; H P Friedl; P A Ward
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 8.  Modulation of the composition of AP-1 complex and its impact on transcriptional activity.

Authors:  B Kaminska; B Pyrzynska; I Ciechomska; M Wisniewska
Journal:  Acta Neurobiol Exp (Wars)       Date:  2000       Impact factor: 1.579

9.  Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines.

Authors:  Yong-Chen Lu; Ira Kim; Elizabeth Lye; Fang Shen; Nobutaka Suzuki; Shinobu Suzuki; Steve Gerondakis; Shizuo Akira; Sarah L Gaffen; Wen-Chen Yeh; Pamela S Ohashi
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

10.  The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing.

Authors:  Satoshi Uematsu; Tsuneyasu Kaisho; Takashi Tanaka; Makoto Matsumoto; Megumi Yamakami; Hiroko Omori; Masahiro Yamamoto; Tamotsu Yoshimori; Shizuo Akira
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

View more
  18 in total

1.  Effects of intratracheal exposure of 2-chloroethyl ethyl sulfide (CEES) on the activation of CCAAT-enhancer-binding protein (C/EBP) and its protection by antioxidant liposome.

Authors:  Somdutta Sinha Roy; Shyamali Mukherjee; Salil K Das
Journal:  J Biochem Mol Toxicol       Date:  2016-11-30       Impact factor: 3.642

2.  Identification of a tissue-specific, C/EBPβ-dependent pathway of differentiation for murine peritoneal macrophages.

Authors:  Derek W Cain; Emily G O'Koren; Matthew J Kan; Mandy Womble; Gregory D Sempowski; Kristen Hopper; Michael D Gunn; Garnett Kelsoe
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

3.  Suppressors of cytokine signaling 3 is essential for FcγR-mediated inflammatory response via enhancing CCAAT/enhancer-binding protein δ transcriptional activity in macrophages.

Authors:  Chunguang Yan; Yanlan Liu; Hongwei Gao; Ximo Wang
Journal:  Exp Cell Res       Date:  2015-07-21       Impact factor: 3.905

4.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

5.  LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells.

Authors:  Kiflai Bein; Michelangelo Di Giuseppe; Steven E Mischler; Luis A Ortiz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

6.  Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.

Authors:  Huifang Tang; Yanlan Liu; Chunguang Yan; Nicos A Petasis; Charles N Serhan; Hongwei Gao
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

7.  Sex differences in the expression of lung inflammatory mediators in response to ozone.

Authors:  Noe Cabello; Vikas Mishra; Utkarshna Sinha; Susan L DiAngelo; Zissis C Chroneos; Ndifreke A Ekpa; Timothy K Cooper; Carla R Caruso; Patricia Silveyra
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-04       Impact factor: 5.464

8.  The effect of human adipose-derived stem cells on lipopolysaccharide-induced acute respiratory distress syndrome in mice.

Authors:  Young Ju Jung; Yun Young Park; Jin Won Huh; Sang-Bum Hong
Journal:  Ann Transl Med       Date:  2019-11

Review 9.  The many faces of C/EBPδ and their relevance for inflammation and cancer.

Authors:  Kuppusamy Balamurugan; Esta Sterneck
Journal:  Int J Biol Sci       Date:  2013-09-20       Impact factor: 6.580

10.  Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury.

Authors:  Shijia Zhang; Svitlana D Danchuk; Kathleen Mp Imhof; Julie A Semon; Brittni A Scruggs; Ryan W Bonvillain; Amy L Strong; Jeffrey M Gimble; Aline M Betancourt; Deborah E Sullivan; Bruce A Bunnell
Journal:  Stem Cell Res Ther       Date:  2013-01-29       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.